Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy

Fig. 3

The results of network pharmacological analysis. a All results in the docking process. b Positive result in the docking process. c The targets selected with KEGG enrichment analysis. d Top 30 enrichment pathways of KEGG enrichment analysis. e Compound-target-pathway network. The node groups from inside to outside are molecule, pathway, and protein targets. The lines are interactions between each other

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us